Screen-positive anxiety and depressive symptoms and their comorbidity among adults in Anhui Province, China: prevalence, regional variations and associated factors
Frontiers in Public Health · 20.11.2026 · 14
DOI: 10.3389/fpubh.2026.1967585 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Public Health, online erschienen am 20.11.2026. Verfasst von Junwei Yan und 3 weiteren Autor:innen. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Depression
Abstract (Originalsprache)
Background
Anxiety and depression are common mental health problems that often occur together. This poses a heavy burden on individuals and healthcare systems. Yet, in Anhui Province, China, evidence from population-based studies on these issues is still limited. This study was designed to assess the prevalence of screen-positive anxiety symptoms, screen-positive depressive symptoms and their comorbidity in the adult population of Anhui Province. We also sought to explore which social and health factors are associated with these conditions.
Methods
We conducted a cross-sectional community-based survey of adults aged 18 years and over in Anhui Province, China. Of 8,460 adults selected by multistage probability sampling, 8,317 returned a valid questionnaire. Screen-positive anxiety symptoms were measured with the 7-item Generalised Anxiety Disorder Scale (GAD-7), while depressive symptoms were evaluated using the 9-item Patient Health Questionnaire (PHQ-9). Comorbidity was defined as a score of ≥10 on both scales. Prevalence is reported with 95% confidence intervals (CI) adjusted for the clustering of respondents within counties or districts. We described intergroup data using numbers and percentages. Univariate and multivariate logistic regression models were employed to identify factors related to anxiety, depression, and their comorbidity.
Results
The analysis included 8,317 adults with complete data. The prevalence of screen-positive anxiety symptoms was 2.12% (95% CI : 1.66–2.57%), of screen-positive depressive symptoms 3.40% (95% CI : 2.56–4.25%), and of their comorbidity 1.12% (95% CI : 0.76–1.47%). Estimates varied widely between districts and counties: from 0.36% to 4.83% for anxiety symptoms, 0.29% to 9.55% for depressive symptoms and 0.00% to 3.92% for comorbidity. In the multivariable model, self-rated health was the strongest correlate. Compared with good self-rated health, poor self-rated health was associated with higher odds of screen-positive anxiety symptoms ( OR = 21.748, 95% CI : 14.633–32.320), depressive symptoms ( OR = 25.057, 95% CI : 17.760–35.351) and comorbidity ( OR = 47.037, 95% CI : 25.490–86.795).
Conclusion
Screen-positive anxiety and depressive symptoms, and their comorbidity, are present but uncommon among adults in Anhui Province. The prevalence differs by region and by subgroup. Poor self-rated health was found to be significantly associated with all three of these outcomes, especially with comorbidity. These results support including mental health screening in community health services. This is especially important for people with poor self-rated health and in regions with relatively high prevalence.
Zitieren
APA
Yan, J., Liu, Y., Xu, X., & Wang, H. (2026). Screen-positive anxiety and depressive symptoms and their comorbidity among adults in Anhui Province, China: prevalence, regional variations and associated factors. Frontiers in Public Health, 14. https://doi.org/10.3389/fpubh.2026.1967585
Vancouver
Yan J, Liu Y, Xu X, Wang H. Screen-positive anxiety and depressive symptoms and their comorbidity among adults in Anhui Province, China: prevalence, regional variations and associated factors. Frontiers in Public Health. 2026;14. doi:10.3389/fpubh.2026.1967585
BibTeX
@article{Yan2026,
author = {Yan, Junwei and Liu, Yong and Xu, Xiaotong and Wang, Hongyu},
title = {Screen-positive anxiety and depressive symptoms and their comorbidity among adults in Anhui Province, China: prevalence, regional variations and associated factors},
journal = {Frontiers in Public Health},
year = {2026},
volume = {14},
doi = {10.3389/fpubh.2026.1967585}
}
EUVIMED